Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2025-12-24 @ 11:54 PM
NCT ID:
NCT05293951
Eligibility Criteria:
Inclusion Criteria:
* Clinical diagnosis of ischemic or hemorrhagic stroke as determined by a stroke neurologist. Stroke will be defined as an acute event of cerebrovascular origin causing focal or global neurologic dysfunction lasting more than 24 hours diagnosed by a neurologist/gerontologist, and confirmed by computed tomography or magnetic resonance imaging.
* ≥3 months post stroke; with no restrictions on how long post stroke.
* Discharged from formal physiotherapy rehabilitation services.
* Unilateral upper limb weakness with a Medical Research Council (MRC) Scale for Strength score greater than 2 (i.e., movement with influence of gravity removed) in the limb to be assessed and treated.
* Functional active range of movement and power in non-hemiparetic side.
* Ambulatory with or without use of a walking device. Must be able to transfer into the Biodex machine.
* Older than 18 yrs.
* Not involved in any other type of structured strength training for the duration of the study.
Exclusion Criteria:
* Diagnosis of additional neurological condition (including more than one stroke) or cardiovascular disease.
* Presence of musculoskeletal conditions affecting the bones and/or soft tissues of the upper extremity.
* Impaired cognition that would affect ability to informed consent (MMSE \<21).
* Presence of aphasia or visual impairments.
* Medications affecting tone less than 3/12 prior.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT05293951
Study Brief:
Protocol Section:
NCT05293951